JPMorgan Chase & Co. Has $86,000 Holdings in PetMed Express, Inc. (NASDAQ:PETS)

JPMorgan Chase & Co. decreased its position in shares of PetMed Express, Inc. (NASDAQ:PETS) by 73.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,481 shares of the company’s stock after selling 64,471 shares during the period. JPMorgan Chase & Co. owned approximately 0.11% of PetMed Express worth $86,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Marshall Wace LLP bought a new stake in shares of PetMed Express during the 2nd quarter worth $46,000. Independent Advisor Alliance bought a new position in PetMed Express in the third quarter valued at about $106,000. Sei Investments Co. grew its holdings in shares of PetMed Express by 8.3% during the second quarter. Sei Investments Co. now owns 44,220 shares of the company’s stock worth $179,000 after purchasing an additional 3,400 shares during the last quarter. Squarepoint Ops LLC acquired a new position in shares of PetMed Express in the second quarter valued at approximately $273,000. Finally, Bleakley Financial Group LLC acquired a new stake in PetMed Express during the 3rd quarter worth approximately $279,000. Institutional investors and hedge funds own 73.33% of the company’s stock.

Insider Transactions at PetMed Express

In other news, Director Leslie C.G. Campbell purchased 15,000 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were acquired at an average price of $5.38 per share, with a total value of $80,700.00. Following the acquisition, the director now directly owns 70,000 shares in the company, valued at approximately $376,600. The trade was a 27.27 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.10% of the stock is owned by corporate insiders.

PetMed Express Stock Up 1.1 %

Shares of PETS opened at $4.81 on Tuesday. The stock has a market cap of $99.37 million, a P/E ratio of -80.17 and a beta of 0.70. The business’s fifty day moving average is $5.08 and its 200 day moving average is $4.26. PetMed Express, Inc. has a 12-month low of $2.90 and a 12-month high of $6.85.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.17. The firm had revenue of $59.57 million during the quarter, compared to the consensus estimate of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. On average, analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current year.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of PetMed Express from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.